CREDIT SUISSE AG/ - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 111 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2014. The put-call ratio across all filers is 1.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$86,000
+62.3%
18,869
+23.8%
0.00%
Q4 2018$53,000
-58.3%
15,243
+20.8%
0.00%
Q3 2018$127,000
-11.2%
12,618
-36.2%
0.00%
Q2 2018$143,000
+15.3%
19,768
-3.4%
0.00%
Q1 2018$124,000
-84.3%
20,460
-75.0%
0.00%
-100.0%
Q4 2017$790,000
+167.8%
81,928
+146.7%
0.00%
Q3 2017$295,000
+10.5%
33,211
+57.2%
0.00%
Q2 2017$267,000
-18.1%
21,124
-31.9%
0.00%
Q1 2017$326,000
+23.5%
31,003
+8.2%
0.00%
Q4 2016$264,000
-46.2%
28,641
-31.2%
0.00%
Q3 2016$491,000
-33.2%
41,624
-26.7%
0.00%
-100.0%
Q2 2016$735,000
-44.0%
56,808
-30.8%
0.00%
-50.0%
Q1 2016$1,313,000
-41.8%
82,147
+4.2%
0.00%
-33.3%
Q4 2015$2,257,000
+36.1%
78,816
+35.4%
0.00%
+50.0%
Q3 2015$1,658,000
-62.9%
58,220
-53.1%
0.00%
-50.0%
Q2 2015$4,463,000
+136.6%
124,239
+283.1%
0.00%
+100.0%
Q1 2015$1,886,000
-15.4%
32,434
-38.7%
0.00%0.0%
Q4 2014$2,230,000
-47.3%
52,910
-51.5%
0.00%
-33.3%
Q3 2014$4,230,000
+758.0%
109,072
+592.0%
0.00%
Q2 2014$493,000
-60.5%
15,761
-47.7%
0.00%
-100.0%
Q1 2014$1,248,000
+67.1%
30,118
+56.2%
0.00%0.0%
Q4 2013$747,000
+31.5%
19,280
+18.8%
0.00%0.0%
Q3 2013$568,00016,2250.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,257,094$92,697,00013.04%
JW Asset Management, LLC 388,346$11,052,0004.00%
Anson Funds Management LP 400,200$11,390,0003.31%
Orbimed Advisors 4,081,800$116,168,0001.17%
SCOPIA CAPITAL MANAGEMENT LP 1,718,487$48,908,0001.05%
Bellevue Asset Management AG 210,000$5,977,0000.98%
NEXT CENTURY GROWTH INVESTORS LLC 788,534$22,441,0000.93%
Rock Springs Capital Management LP 308,000$8,766,0000.71%
JUNCTURE WEALTH STRATEGIES, LLC 18,502$527,0000.43%
B. Riley Wealth Management, Inc. 8,600$244,0000.35%
View complete list of INSYS THERAPEUTICS INC NEW shareholders